Paris/Munich — Stefan Kalten­ba­cher (56), photo, will head Bryan, Garnier and Co. ’s German-spea­king invest­ment banking acti­vi­ties in the life scien­ces sector (DACH region) from May 1, 2020. The new Mana­ging Direc­tor has exten­sive gene­ral manage­ment expe­ri­ence in the phar­maceu­ti­cal and medi­cal tech­no­logy indus­try as well as in private equity: Among other things, he was respon­si­ble for the Nort­hern and Central Euro­pean busi­ness of the medi­cal tech­no­logy company Care­Fu­sion (now part of Becton Dick­in­son), led the medi­cal device sector of John­son & John­son in Germany and Austria, and was a member of John­son & Johnson’s Stra­tegy Team Europe. Prior to that, he worked in Paris and London as direc­tor for the inter­na­tio­nal diagno­stics divi­sion of Bayer AG. Most recently, as Mana­ging Direc­tor of an owner-mana­­ged, inde­pen­dent M&A consul­tancy, he advi­sed a large number of growth compa­nies and estab­lished compa­nies in the German-spea­king region and was Senior Advi­sor to Deut­sche Betei­li­gungs­ge­sell­schaft, Frank­furt, on its enga­ge­ments in the life scien­ces sector.

“Parti­cu­larly in the life scien­ces sector, indus­try expe­ri­ence is abso­lut­ely essen­tial and we are deligh­ted to have gained such an expe­ri­en­ced indus­try expert for our German team,” empha­si­zes Falk Müller-Veerse, who as Part­ner is respon­si­ble for Bryan, Garnier & Co.’s busi­ness in the DACH region.

The health­care indus­try is a central focus of the invest­ment bank for tech­no­logy compa­nies, which was foun­ded in Paris and London in 1996: Bryan, Garnier & Co. was invol­ved in the successful Nasdaq IPO of biotech company BionTech, accom­pa­nied medi­cal tech­no­logy company Medar­tis to the Swiss stock exch­ange, and orchestra­ted a number of private finan­cing rounds of life scien­ces start-ups with global inves­tors, among others.

About Bryan, Garnier & Co
Bryan, Garnier & Co, foun­ded in 1996 in Paris and London, is an invest­ment bank focu­sed on Euro­pean growth compa­nies with a presence in London, Paris, Munich, Stock­holm, Oslo, Reykja­vík, New York, Palo Alto and Shang­hai. As an inde­pen­dent full-service invest­ment bank, it offers compre­hen­sive finan­cing advice and support along the entire life cycle of its clients — from initial finan­cing rounds to a poten­tial sale or IPO with subse­quent follow-up finan­cing. The range of services includes equity analy­sis, equity sales and trading, private and public capi­tal raising, and M&A advi­sory for growth compa­nies and their inves­tors. The focus is on the growth sectors of tech­no­logy, health­care, bran­ded and consu­mer goods, and busi­ness services. Bryan Garnier is a regis­tered broker and licen­sed with the FCA in Europe and FINRA in the US.